Fisher Wallace Neurostimulation & Depression Study

Neurostimulation & Depression Study

Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.

Inclusion criteria:

• Age greater than or equal to 21
• US resident
• Can receive packages to their home via UPS/Fedex/USPS
• Major Depressive Disorder
• PHQ-8 Score greater than 10 (show some signs of mild to moderate depression)
• PHQ-8 Score less than 20 (given remote study serious depressed should be excluded)
• Read/write English
• have not contemplated suicide in the past year
• not been institutionalized for mental health issues.
• not currently experiencing problems with alcohol or drug abuse
• can commit to not drinking alcohol 4 hours before bedtime for the duration of the study
• can commit to two (2) 20 minute sessions per day for 8 weeks
• has not used a brain stimulation treatment in one year
• no suspected or known history of heart disease
• no pacemaker
• not under medical supervision for other serious medical condition
• not taking opioids
• is a resident of states in which we have licensed medical professionals